JP2010280669A5 - - Google Patents

Download PDF

Info

Publication number
JP2010280669A5
JP2010280669A5 JP2010157000A JP2010157000A JP2010280669A5 JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5 JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010157000 A JP2010157000 A JP 2010157000A JP 2010280669 A5 JP2010280669 A5 JP 2010280669A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
independently
case
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010157000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010280669A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010280669A publication Critical patent/JP2010280669A/ja
Publication of JP2010280669A5 publication Critical patent/JP2010280669A5/ja
Withdrawn legal-status Critical Current

Links

JP2010157000A 2002-05-21 2010-07-09 置換複素環式化合物および使用方法 Withdrawn JP2010280669A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38269902P 2002-05-21 2002-05-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004507465A Division JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Publications (2)

Publication Number Publication Date
JP2010280669A JP2010280669A (ja) 2010-12-16
JP2010280669A5 true JP2010280669A5 (enExample) 2011-10-06

Family

ID=29584444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法
JP2010157000A Withdrawn JP2010280669A (ja) 2002-05-21 2010-07-09 置換複素環式化合物および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004507465A Expired - Fee Related JP4606161B2 (ja) 2002-05-21 2003-05-13 置換複素環式化合物および使用方法

Country Status (10)

Country Link
US (1) US7026326B2 (enExample)
EP (1) EP1506186A1 (enExample)
JP (2) JP4606161B2 (enExample)
AR (1) AR039842A1 (enExample)
AU (1) AU2003234628B2 (enExample)
CA (1) CA2485166A1 (enExample)
MX (1) MXPA04011470A (enExample)
PL (1) PL376575A1 (enExample)
TW (1) TW200406399A (enExample)
WO (1) WO2003099808A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06001002A (es) 2003-07-25 2006-04-11 Amgen Inc Piridonas y pirimidinonas sustituidas con propiedades antiinflamatorias.
US7429594B2 (en) 2003-08-20 2008-09-30 Amgen Inc. Substituted heterocyclic compounds and methods of use
CA2591922A1 (en) * 2004-12-24 2006-06-29 Prosidion Limited G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
US7528448B2 (en) * 2006-07-17 2009-05-05 E.I. Du Pont De Nemours And Company Thin film transistor comprising novel conductor and dielectric compositions
US8062824B2 (en) * 2006-07-17 2011-11-22 E. I. Du Pont De Nemours And Company Thermally imageable dielectric layers, thermal transfer donors and receivers
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
MY152078A (en) 2007-09-14 2014-08-15 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
US7666568B2 (en) * 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Composition and method for providing a patterned metal layer having high conductivity
US7666567B2 (en) 2007-10-23 2010-02-23 E. I. Du Pont De Nemours And Company Negative imaging method for providing a patterned metal layer having high conductivity
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CA2744138C (en) 2008-11-28 2015-08-11 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
AU2010246609B2 (en) 2009-05-12 2013-09-05 Addex Pharma S.A. 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EA020671B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
WO2012062751A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
WO2012118850A1 (en) 2011-02-28 2012-09-07 Array Biopharma Inc. Serine/threonine kinase inhibitors
ES2552989T3 (es) 2011-08-04 2015-12-03 Array Biopharma, Inc. Compuestos de quinazolina como inhibidores de la cinasa de serina / treonina
WO2013066729A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN106349217B (zh) * 2012-03-01 2020-08-28 阵列生物制药公司 丝氨酸/苏氨酸激酶抑制剂
HK1210174A1 (en) 2012-08-27 2016-04-15 Array Biopharma, Inc. Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
WO2018190352A1 (ja) * 2017-04-11 2018-10-18 三井化学アグロ株式会社 ピリドン化合物およびそれを有効成分とする農園芸用殺菌剤
ES2910839T3 (es) * 2017-08-23 2022-05-13 Sprint Bioscience Ab Compuestos de piridilpiridona
DK3672948T3 (da) * 2017-08-23 2022-12-05 Sprint Bioscience Ab Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
CN117083064A (zh) 2020-11-25 2023-11-17 德西费拉制药有限责任公司 作为vps34抑制剂用于治疗病毒感染的吡啶基吡啶酮衍生物
EP4674841A2 (en) * 2022-02-16 2026-01-07 Duke Street Bio Limited Pharmaceutical compound
AU2023406476A1 (en) 2022-12-02 2025-06-05 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
WO1995009917A1 (en) 1993-10-07 1995-04-13 The Regents Of The University Of California Genetically engineered bispecific tetravalent antibodies
WO1996018412A1 (en) 1994-12-12 1996-06-20 Beth Israel Hospital Association Chimeric cytokines and uses thereof
NZ331163A (en) 1996-02-09 2000-07-28 Amgen Inc Composition comprising interleukin-1 inhibitor and hydrogel ester (hyaluronan) for treating inflammatory diseases
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
AR038955A1 (es) 1996-12-05 2005-02-02 Amgen Inc Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
AU735901C (en) * 1996-12-05 2004-02-12 Amgen, Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US6410729B1 (en) * 1996-12-05 2002-06-25 Amgen Inc. Substituted pyrimidine compounds and methods of use
EP2002846B1 (en) 1996-12-06 2017-01-25 Amgen Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
KR19980066046A (ko) 1997-01-18 1998-10-15 정용훈 고역가의 CTLA4-Ig 융합단백질
HU226175B1 (en) 1997-04-17 2008-06-30 Amgen Inc Human ob protein suspension, process for producing thereof and use for production of pharmaceutical composition
AU2002302420B2 (en) * 2001-03-15 2007-12-06 Basf Aktiengesellschaft 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi

Similar Documents

Publication Publication Date Title
JP2010280669A5 (enExample)
JP2012092103A5 (enExample)
JP2013102146A5 (ja) 化合物
JP2015042636A5 (ja) 有機化合物
JP2013040159A5 (ja) 有機金属錯体
JP2016503300A5 (enExample)
JP2014500861A5 (enExample)
JP2010241801A5 (enExample)
JP2015505296A5 (enExample)
JP2011121940A5 (ja) 発光素子
JP2010254680A5 (ja) 複素環化合物、及び発光素子
JP2016540742A5 (enExample)
JP2013542218A5 (enExample)
JP2010095546A5 (enExample)
JP2011528706A5 (enExample)
JP2010523522A5 (enExample)
JP2013100341A5 (enExample)
JP2012109092A5 (enExample)
JP2012149045A5 (ja) ベンゾ[b]ナフト[1,2−d]フラン化合物
JP2015143283A5 (enExample)
JP2012109091A5 (enExample)
JP2013147496A5 (ja) 有機金属錯体
JP2014509612A5 (enExample)
JP2014526533A5 (enExample)
JP2013537203A5 (enExample)